Identification of a New Family of Genes Involved in β-1,2-Mannosylation of Glycans in Pichia pastoris and Candida albicans*

Structural studies of cell wall components of the pathogenic yeast Candida albicans have demonstrated the presence of β-1,2-linked oligomannosides in phosphopeptidomannan and phospholipomannan. During C. albicans infection, β-1,2-oligomannosides play an important role in host/pathogen interactions by acting as adhesins and by interfering with the host immune response. Despite the importance of β-1,2-oligomannosides, the genes responsible for their synthesis have not been identified. The main reason is that the reference species Saccharomyces cerevisiae does not synthesize β-linked mannoses. On the other hand, the presence of β-1,2-oligomannosides has been reported in the cell wall of the more genetically tractable C. albicans relative, P. pastoris. Here we present the identification, cloning, and characterization of a novel family of fungal genes involved in β-mannose transfer. Employing in silico analysis, we identified a family of four related new genes in P. pastoris and subsequently nine homologs in C. albicans. Biochemical, immunological, and structural analyses following deletion of four genes in P. pastoris and deletion of four genes acting specifically on C. albicans mannan demonstrated the involvement of these new genes in β-1,2-oligomannoside synthesis. Phenotypic characterization of the strains deleted in β-mannosyltransferase genes (BMTs) allowed us to describe the stepwise activity of Bmtps and acceptor specificity. For C. albicans, despite structural similarities between mannan and phospholipomannan, phospholipomannan β-mannosylation was not affected by any of the CaBMT1–4 deletions. Surprisingly, depletion in mannan major β-1,2-oligomannoside epitopes had little impact on cell wall surface β-1,2-oligomannoside antigenic expression.

[1]  F. Smith,et al.  A Colorimetric Method for the Determination of Sugars , 1951, Nature.

[2]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[3]  S. Suzuki,et al.  Immunochemical study on the mannans of Candida albicans NIH A-207, NIH B-792, and J-1012 strains prepared by fractional precipitation with cetyltrimethylammonium bromide. , 1985, Archives of biochemistry and biophysics.

[4]  D. G. Davis,et al.  Practical aspects of two-dimensional transverse NOE spectroscopy , 1985 .

[5]  A. Dell,et al.  Structural studies of the O-antigen polysaccharide of Salmonella thompson, serogroup C1 (6,7). , 1988, Carbohydrate research.

[6]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.

[7]  S. Ho,et al.  Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. , 1989, Gene.

[8]  M. Arai,et al.  Structural identification of an epitope of antigenic factor 5 in mannans of Candida albicans NIH B-792 (serotype B) and J-1012 (serotype A) as beta-1,2-linked oligomannosyl residues , 1992, Infection and immunity.

[9]  P. Jacquinot,et al.  Mapping of Candida albicans oligomannosidic epitopes by using monoclonal antibodies , 1992, Infection and immunity.

[10]  S. Suzuki,et al.  Sequential nuclear magnetic resonance assignment of beta-1,2-linked mannooligosaccharides isolated from the phosphomannan of the pathogenic yeast Candida albicans NIH B-792 strain. , 1992, Biochemistry.

[11]  S. Suzuki,et al.  Evidence for oligomannosyl residues containing both beta-1,2 and alpha-1,2 linkages as a serotype A-specific epitope(s) in mannans of Candida albicans , 1992, Infection and immunity.

[12]  J. Wieruszeski,et al.  Complete 1H- and 13C-resonance assignments for D-mannooligosaccharides of the beta-D-(1-->2)-linked series released from the phosphopeptidomannan of Candida albicans VW.32 (serotype A). , 1992, Carbohydrate research.

[13]  Begoña,et al.  Characterization of Candida albicans cell wall antigens with monoclonal antibodies , 1993, Infection and immunity.

[14]  A. Molinari,et al.  Differential cell surface expression of mannoprotein epitopes in yeast and mycelial forms of Candida albicans. , 1993, European journal of cell biology.

[15]  S. Suzuki [Immunochemical study on mannan, the antigenic polysaccharide of pathogenic yeasts in man of genus Candida]. , 1995, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[16]  D. Sanglard,et al.  Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors , 1996, Antimicrobial agents and chemotherapy.

[17]  T. Odani,et al.  Cloning and analysis of the MNN4 gene required for phosphorylation of N-linked oligosaccharides in Saccharomyces cerevisiae. , 1996, Glycobiology.

[18]  T. Kanbe,et al.  Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies , 1997, Infection and immunity.

[19]  J. Berman,et al.  Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. , 1998, Science.

[20]  J. Briggs,et al.  A high-throughput microscale method to release N-linked oligosaccharides from glycoproteins for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis. , 1998, Glycobiology.

[21]  T. Odani,et al.  Mannosylphosphate transfer to yeast mannan. , 1999, Biochimica et biophysica acta.

[22]  J. Mccusker,et al.  Three new dominant drug resistance cassettes for gene disruption in Saccharomyces cerevisiae , 1999, Yeast.

[23]  Xuewen Pan,et al.  Heterologous URA3MX cassettes for gene replacement in Saccharomyces cerevisiae , 1999, Yeast.

[24]  A. Mitchell,et al.  Rapid Hypothesis Testing with Candida albicans through Gene Disruption with Short Homology Regions , 1999, Journal of bacteriology.

[25]  J. Latgé,et al.  Aspergillus fumigatus and Aspergillosis , 1999, Clinical Microbiology Reviews.

[26]  M. Gentzsch,et al.  Protein O-mannosylation. , 1999, Biochimica et biophysica acta.

[27]  N. Dean,et al.  Asparagine-linked glycosylation in the yeast Golgi. , 1999, Biochimica et biophysica acta.

[28]  P. Sundstrom,et al.  Adhesins in Candida albicans. , 1999, Current opinion in microbiology.

[29]  D. McClish,et al.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  Alistair J. P. Brown,et al.  CIp10, an efficient and convenient integrating vector for Candida albicans , 2000 .

[31]  E. Vinogradov,et al.  Isolation and characterization of non-labeled and 13C-labeled mannans from Pichia pastoris yeast. , 2000, Carbohydrate research.

[32]  T. Goins,et al.  Relative Abundance of Oligosaccharides in CandidaSpecies as Determined by Fluorophore-Assisted Carbohydrate Electrophoresis , 2000, Journal of Clinical Microbiology.

[33]  D. Poulain,et al.  β-1,2-Linked Oligomannosides from Candida albicans Bind to a 32-Kilodalton Macrophage Membrane Protein Homologous to the Mammalian Lectin Galectin-3 , 2000, Infection and Immunity.

[34]  P. Trinel,et al.  Candida albicans-Derived β-1,2-Linked Mannooligosaccharides Induce Desensitization of Macrophages , 2000, Infection and Immunity.

[35]  M. Whiteway,et al.  Transcriptional control of cell type and morphogenesis in Candida albicans. , 2000, Current opinion in microbiology.

[36]  L. Hoyer,et al.  The ALS gene family of Candida albicans. , 2001, Trends in microbiology.

[37]  A. Helenius,et al.  Intracellular functions of N-linked glycans. , 2001, Science.

[38]  Gerald R. Fink,et al.  The glyoxylate cycle is required for fungal virulence , 2001, Nature.

[39]  R. Calderone,et al.  Virulence factors of Candida albicans. , 2001, Trends in microbiology.

[40]  A. Otter,et al.  The Unique Solution Structure and Immunochemistry of theCandida albicans β-1,2-Mannopyranan Cell Wall Antigens* 210 , 2002, The Journal of Biological Chemistry.

[41]  F. Dromer,et al.  Synthetic Analogues of β-1,2 Oligomannosides Prevent Intestinal Colonization by the Pathogenic Yeast Candida albicans , 2002, Antimicrobial Agents and Chemotherapy.

[42]  Thierry Jouault,et al.  Candida albicans Phospholipomannan, a New Member of the Fungal Mannose Inositol Phosphoceramide Family* , 2002, The Journal of Biological Chemistry.

[43]  P. Codogno,et al.  Common origin and evolution of glycosyltransferases using Dol-P-monosaccharides as donor substrate. , 2002, Molecular biology and evolution.

[44]  M. McConville,et al.  Evidence That Intracellular β1-2 Mannan Is a Virulence Factor in Leishmania Parasites* , 2003, Journal of Biological Chemistry.

[45]  J. Wendland,et al.  New modules for PCR‐based gene targeting in Candida albicans: rapid and efficient gene targeting using 100 bp of flanking homology region , 2003, Yeast.

[46]  T. Idziorek,et al.  Candida albicans Phospholipomannan Promotes Survival of Phagocytosed Yeasts through Modulation of Bad Phosphorylation and Macrophage Apoptosis* , 2003, The Journal of Biological Chemistry.

[47]  Osamu Takeuchi,et al.  Candida albicans phospholipomannan is sensed through toll-like receptors. , 2003, The Journal of infectious diseases.

[48]  Byung-Kwon Choi,et al.  Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[49]  B. Hube,et al.  Candida albicans proteinases and host/pathogen interactions , 2004, Cellular microbiology.

[50]  G. Strecker,et al.  Inactivation of CaMIT1 Inhibits Candida albicans Phospholipomannan β-Mannosylation, Reduces Virulence, and Alters Cell Wall Protein β-Mannosylation* , 2004, Journal of Biological Chemistry.

[51]  D. Poulain,et al.  Candida albicans cell wall glycans, host receptors and responses: elements for a decisive crosstalk. , 2004, Current opinion in microbiology.

[52]  N. Gow,et al.  Loss of Cell Wall Mannosylphosphate in Candida albicans Does Not Influence Macrophage Recognition* , 2004, Journal of Biological Chemistry.

[53]  R. Davidson,et al.  Functional analysis of the ALG3 gene encoding the Dol-P-Man: Man5GlcNAc2-PP-Dol mannosyltransferase enzyme of P. pastoris. , 2004, Glycobiology.

[54]  John H Rex,et al.  Invasive candidiasis in immunocompromised hospitalized patients. , 2005, Archives of medical research.

[55]  D. Singleton,et al.  Surface Hydrophobicity Changes of Two Candida albicans Serotype B mnn4Δ Mutants , 2005, Eukaryotic Cell.

[56]  M. Schaller,et al.  Virulence of the Fungal Pathogen Candida albicans Requires the Five Isoforms of Protein Mannosyltransferases , 2005, Infection and Immunity.

[57]  S. Wildt,et al.  The humanization of N-glycosylation pathways in yeast , 2005, Nature Reviews Microbiology.

[58]  Brice Enjalbert,et al.  Role of the Hog1 stress-activated protein kinase in the global transcriptional response to stress in the fungal pathogen Candida albicans. , 2005, Molecular biology of the cell.

[59]  D. Poulain,et al.  Comparative analysis of cell wall surface glycan expression in Candida albicans and Saccharomyces cerevisiae yeasts by flow cytometry. , 2006, Journal of immunological methods.

[60]  Spencer J. Williams,et al.  Leishmania beta-1,2-mannan is assembled on a mannose-cyclic phosphate primer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Alistair J. P. Brown,et al.  Outer Chain N-Glycans Are Required for Cell Wall Integrity and Virulence of Candida albicans* , 2006, Journal of Biological Chemistry.

[62]  D. Hsu,et al.  Galectin-3 Induces Death of Candida Species Expressing Specific β-1,2-Linked Mannans1 , 2006, The Journal of Immunology.